AMG downgraded to neutral as organic EBITDA growth deteriorates, per Goldman

Published 06/01/2025, 13:30
AMG downgraded to neutral as organic EBITDA growth deteriorates, per Goldman

On Monday, Goldman Sachs analyst Alexander Blostein adjusted the firm's stance on Affiliated Managers Group (NYSE:AMG), downgrading the stock from Buy to Neutral and setting a price target of $191.00. The downgrade reflects concerns about the company's organic EBITDA growth, which is anticipated to decline to -3% in 2025.

This negative outlook is attributed to the underperformance of AMG's Active Equity affiliates, which contribute 45% of EBITDA, potentially increasing flow risks and diminishing the positive effects from the firm's Alternatives (Alts) business segment.

Blostein notes that despite AMG's capital flexibility, recent high acquisition multiples in the Alternatives space might constrain the company's opportunities. The analyst's estimates for AMG's earnings per share (EPS) and EBITDA from 2025 to 2027 are slightly below the consensus, suggesting there might be a downside to AMG's stock multiple if organic growth continues to decline.

The new price target of $191.00 is based on a 7.4X forward price-to-earnings (P/E) multiple, calculated using projected earnings from the fifth to the eighth quarter ahead. This valuation reflects a more cautious view of AMG's future financial performance, particularly in the context of the firm's Active Equity segment's challenges.

Blostein's commentary emphasizes the risks to AMG's growth trajectory, specifically pointing to the potential deterioration of the company's organic EBITDA and the high costs of acquisitions in the Alternatives market. The revised price target and stock rating suggest a reevaluation of AMG's prospects in the face of these headwinds.

Investors and market watchers will likely monitor AMG's performance closely, especially with regard to its Active Equity affiliates and the Alts business, to see if the company can navigate the challenges outlined by Goldman Sachs and achieve its financial targets despite the predicted downturn in organic EBITDA growth.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.